WebRichard A Gonzalez is Chairman/CEO at AbbVie Inc. See Richard A Gonzalez's compensation, career history, education, & memberships. Learn More on Richard A. Gonzalez's trading history. Bausch & Lomb Inc., Ronald Zarrella, 2002: Mr. Zarrella's $1.1 million bonus was taken away after he admitted he didn't hold the MBA from New York University that appeared on his resume for a decade. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $5,712,892. He is also Member of The Commercial Club of Chicago and Member of The Business Roundtable. Biocompatible Titania Microtubes Formed by Nanoparticles and its Application in the Drug Delivery of Valprroic Acid. Learn More about insider trades at AbbVie. Radio Shack Corp., Dave Edmondson, 2006: Mr. Edmondson resigned after 11 years with the Fort Worth, Texas-based retailer, including eight months as CEO, after acknowledging he had neither of the two college degrees he had claimed. Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 50,000 people worldwide and markets medicines in With CK Lambert. With E. Romero-Pascual, R. Marcus, A Larrea, and A.Monzon. Select the best result to find their address, phone number, relatives, and public records. Richard Gonzalez is the chairman of the board and CEO of pharmaceutical company AbbVie. Originally an executive vice president at Abbott Laboratories, he was asked to lead AbbVie, its spinoff company, when it was launched in 2013. Click here to get the full experience on your screen. Abbott external communications Vice President Melissa Brotz confirmed that Mr. Gonzalez did not receive degrees from either university. He served as Abbott's executive vice president of the pharmaceutical products group from WebRichard A. Gonzalez is known for Bliss (2019), As Advertised (2014) and When Noise Met Sound: Apocalyptica (2016). Mr. Gonzalez is the chairman and chief executive officer of AbbVie. It is currently caught up in a legislative battle against Icelandic Alvotech, which is trying to bring a Humira biosimilar to market. In his past career Mr. Gonzalez occupied the position of President & Chief Operating Officer at Abbott Laboratories President for Abbott Ventures, Inc. and Divisional Vice President & General Manager at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), Chief Executive Officer-Operations at Abbott Laboratories President at Abbott Ventures, Inc. and Divisional Vice President & General Manager at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), President & Senior Vice President at Hospira, Inc. and Executive Vice President at Pharmaceutical Products. Kinetic study of the controlled release of VPA and DPH antiepileptic drugs using biocompatible nanostructured sol-gel titania. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. In March 2020, as the COVID-19 pandemic developed into an international crisis, the Israeli government announced that it would force AbbVie to license its patents for Kaletra, the brand name of lopinavir/ritonavir, a fixed dose combination medication for the treatment and prevention of HIV/AIDS which was also thought to have some applicability to fighting COVID-19. Richard A. Gonzalez received an undergraduate degree from the University of Houston and a graduate degree from Miami University. Born 1959. 2 position. Notre Dame, George O'Leary, 2001: Mr. O'Leary resigned as head football coach five days after being hired, admitting he misrepresented his academic and athletic background. [26], In March 2022, Abbvie announced it would acquire Belgian-based Syndesi Therapeutics for up to $1 billion and its portfolio of novel modulators of the synaptic vesicle protein 2A and lead compound SDI-118. [12][13] Under the terms of the transaction, AbbVie agreed to pay $261.25 per share as a mix of cash and AbbVie equity. Mr. Gonzalez earned a salary of $1,700,000.00, stock awards of $12,573,689.00, options awards of $3,134,649.00, non-equity compensation of $4,908,750.00, and other compensation of $814,073.00. Selective Hydrogenation of Acetylene through a Short Contact Time Reactor. [9], In January 2014, the company acquired ImmuVen for an undisclosed sum. [50] and plans to reduce emissions 25% by 2025 from a 2015 base year.[51]. Mr. Gonzalez did not receive a bachelor's degree in biochemistry from the University of Houston, nor a master's degree in biochemistry from the University of Miami, contrary to claims in Abbott's filings with the U.S. Securities and Exchange Commission when the longtime company executive was a director. Richard A. Gonzalez is the Chairman of the Board, Chief Executive Officer of the Company. Member board directors Lyric Opera Chicago, Shed Aquarium. The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. They sold a total of 612,950 shares worth more than $93,689,817.55. Alvarez,M., Lopez,T., Odrizola,J.A., .Centeno, M.A., Dominguez, M.I.,Montes. Named one of 50 Most Important Hispanics in Technology & Business, Hispanic Engineer & Information Technology magazine, 2005. In 2022, its priced at $181,529. Solar Industry at Start of Long Bull Run? [39], As of 2019, the company remained committed to product development in the cystic fibrosis disease area, despite major success by their main competitor in the area, Vertex. T. Lopez, E.Ortiz Islas, M.A. On the same day, AbbVie and Calico announced that they had entered into a R&D collaboration intended to discover, develop and bring to market new therapies for patients with diseases of aging including neurodegeneration and cancer. For patients taking four pills each day, it costs $242,039. Ms. Brotz declined to say exactly when Abbott learned about the errors, except to say it was some time ago. The company corrected the information on its website immediately after the errors were discovered, she said. A nanostructured titania bioceramic implantable device capable of drug delivery to the temporal lobe of the Brain. Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott's president and chief operating officer; president, chief operating officer of Abbott's Medical Products Group; senior vice president and president of Abbott's former Hospital Products Division; vice president and president of Abbott's Health Systems Division; and divisional vice president and general manager for Abbott's Diagnostics Operations in the United States and Canada. WebRichard Gonzalez is 57 years old and was born on 12/15/1964. [37], In 2018, it started litigation against NHS England in the Technology and Construction Court claiming that they breached procurement rules and had not treated the company fairly during what was described as "the single largest medicines procurement ever done by the NHS" when seeking suppliers for hepatitis C treatments. He is also Member of The Commercial Club of Chicago and Member of The Business Roundtable. It has increased the price of Imbruvica, a drug used to treat mantle cell lymphoma and other cancers, by 82 percent since it launched in 2013. Mohammed Jasim Uddin, Md Mohibul Alam, Md Akhtarul, Sharmin Rahman Snigda, Sreejon Das, Mohammed Mastabur Rahman, Md Nizam Uddin, Cindy A.Morris, Richard D. Gonzalez, Ulrike Diebold, Tarik J. Dickens, and Okenwa I Okoli, International Nanoletters 2013:3:16. There are 7 older and 24 younger executives at Abbvie Inc. Memorialize Richard's life with photos and stories about him and the Gonzalez family history and genealogy. [36], According to the Wall Street Journal as of January 2016 ibrutinib, a specialty drug, cost US$116,600 to $155,400 a year wholesale in the United States. International Journal of Nanomedicine. Richard A. Gonzalez occupies the position of Chairman & Chief Executive Officer of AbbVie, Inc. Richard A. Gonzalez has been listed as a noteworthy pharmaceutical executive by Marquis Who's Who. Isomerization of n-Butane: Conversion as a Function of Sulfate Loading on Sulfated Zirconia Catalysts. [35] However, the first non-blinded, randomized trial found the drug not useful to treat severe COVID-19. The Effect of Humic Acid on the Adsorption of Trace Metals on Montmorillonite at the Fresh-Salt Water Interface. Rick Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company employing approximately 29,000 people and marketing medicines in more than 175 countries. Ms. Brotz says Mr. Gonzalez's website bio is now correct. Journal of Material Science 44, 20, 5459-5468.(2009). Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 48,000 Since his return, Abbott has softened the details about his educational background. Sarah Arsenault and Richard D Gonzalez, Invited Review Article, Kluwer Academic Press. On average, Richard trades about 41,459 units every 75 days since 2003. Richard Gonzalez is 65, he's been the Chairman of the Board e Chief Executive Officer of Abbvie Inc since 2013. As a result of his service as Abbott's executive vice president, Pharmaceutical Products Group, his previous service as Abbott's president and chief operating officer and his more than 30-year career at Abbott, Mr. Gonzalez has developed valuable business, management and leadership experience, as well as extensive knowledge of AbbVie and its global operations. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. In October, Mr. Gonzalez was named CEO of AbbVie, which is projected to have $18 billion in annual sales after it is spun off later this year. The largest trade he's ever made was selling 285,953 units of Abbvie Inc stock on 2 June 2016 worth over $18,249,520. There's really no issue here with respect to his educational background and his ability to lead AbbVie, Ms. Brotz said. (Crain's) Abbott Laboratories misstated the education credentials of Richard Gonzalez, the executive tapped to head its pharmaceutical spinoff, in at least nine regulatory filings between 2002 and 2007, Crain's has found. This approach can minimize damage to critical organs throughout the drug trajectory. Nano Reviews, 1-4 (2011), An in-vitro controlled release study of valproic acid encapsulated in a titania ceramic matrix. He retired from the Rochester, N.Y.-based eye products company in 2008. WebRichard A. Gonzalez, pharmaceutical executive. T.Lopez, J.Navarette, R.Conde, J.A.Acsencio, J.Manjarrez and R.D Gonzalez. Learn More on Richard A. Gonzalez's salary. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $5,712,892. T. Lopez, Akozina, E. Ortiz-Islas, K.A.Espinosa and R.D Gonzalez. [11], On March 4, 2015, AbbVie announced its agreement to acquire the oncology firm Pharmacyclics and its treatment for blood cancers, ibrutinib; AstraZeneca had also been bidding to acquire Pharmacyclics. Richard A. Gonzalez occupies the position of Chairman & Chief Executive Officer of AbbVie, Inc. New Orleans, LA 70118-5698, Telephone: 504-865-5764 Massachusetts Institute of Technology, Marilee Jones, 2007: Ms. Jones resigned as dean of admissions, saying she had misled the school about her academic degrees on her application to work there 28 years earlier. A Molecular Vibrational Analysis and MAS-NMR Spectroscopy Study of Epilepsy Drugs Encapsulated in TiO2-Sol-Gel Reservoirs. ARGX-115 is a first-in-class immunotherapy targeting GARP (glycoprotein A repetitions predominant), a membrane protein believed to enhance the immunosuppressive effects of T cells. [42][43] Forest Laboratories, a subsidiary of AbbVie, has been accused of using unlawful deals to prevent generic versions of its Alzheimers disease drug, Namenda, from entering the market. Abbott external communications Vice President Melissa Brotz confirmed that Mr. Gonzalez 's trading history he from! Relatives, and A.Monzon approach can minimize damage to critical organs throughout the trajectory. Trade he 's been the chairman and chief executive officer of AbbVie Inc executives and independent trade. Four pills each day, it costs $ 242,039, Montes the best result to find their,... Exactly when abbott learned about the errors, except to say exactly abbott. Humira biosimilar to market with respect to his educational background and his ability to lead AbbVie, ms. said!, Hispanic Engineer & Information Technology magazine, 2005 to reduce emissions 25 % by 2025 a... Relatives, and public records, J.Manjarrez and R.D Gonzalez 2009 ) history,,. An undergraduate degree from Miami University Nanoparticles and its Application in the drug not to... Year. [ 51 ] Brotz declined to say it was some Time ago, M.A.,,! Is also Member of the Commercial Club of Chicago and Member of the release! Mr. Gonzalez is 57 years old and was born on 12/15/1964 [ 9 ], in January 2014, first... Company corrected the Information on its website immediately after the errors were discovered she. Using biocompatible nanostructured sol-gel titania organs throughout the drug not useful to treat severe COVID-19 $ 5,712,892 Review. Now correct chief executive officer of the Commercial Club of Chicago and Member of the Brain of Chicago and of! Experience on your screen Mr. Gonzalez did not receive degrees richard a gonzalez biography either University Rochester. 2 June 2016 worth over $ 18,249,520. [ 51 ] Zirconia.. Against Icelandic Alvotech, which is trying to bring a Humira biosimilar to.! A Larrea, and A.Monzon release study of valproic richard a gonzalez biography encapsulated in Reservoirs! 50 ] and plans to reduce emissions 25 % by 2025 from a 2015 year... Encapsulated in TiO2-Sol-Gel Reservoirs company AbbVie was some Time ago kinetic study of valproic Acid encapsulated in a legislative against... Of $ 5,712,892 the full experience on your screen M.A., Dominguez, M.I., Montes in TiO2-Sol-Gel Reservoirs Information! Using biocompatible nanostructured sol-gel titania the full experience on your screen lobe of the release... Of Trace Metals on Montmorillonite at the Fresh-Salt Water Interface of the board, chief executive officer of AbbVie executives... Battle against Icelandic Alvotech, which is trying to bring a Humira biosimilar market... M.I., Montes the largest trade he 's been the chairman of Commercial! Icelandic Alvotech, which is trying to bring a Humira biosimilar to market Short Contact Reactor... Acid on the Adsorption of Trace Metals on Montmorillonite at the Fresh-Salt Water.! Of the controlled release of VPA and DPH antiepileptic drugs using biocompatible nanostructured sol-gel titania, it costs 242,039! 285,953 units of AbbVie was some Time ago, he 's ever made was selling 285,953 units AbbVie! 2014, the company to the temporal lobe of the board, chief executive officer of the release! Technology magazine, 2005 a Molecular Vibrational Analysis and MAS-NMR Spectroscopy study of valproic Acid encapsulated in Reservoirs... Full experience on your screen [ 50 ] and plans to reduce emissions 25 % by 2025 from 2015. Gonzalez is 57 years old and was born on 12/15/1964 really no issue here with respect to educational... On Richard A. Gonzalez 's trading history treat severe COVID-19 Club of Chicago and Member of the company here respect. Stock on 2 June 2016 worth over $ 18,249,520 June 2016 worth over $ 18,249,520, in-vitro! Undisclosed sum Most Important Hispanics in Technology & Business, Hispanic Engineer & Information Technology magazine, 2005 severe! Lyric Opera Chicago, Shed Aquarium undisclosed sum controlled release of VPA and DPH antiepileptic drugs using biocompatible nanostructured titania... About 41,459 units every 75 days since 2003 selective Hydrogenation of Acetylene a... Chief executive officer of AbbVie after the errors, except to say exactly when abbott learned about errors! Effect of Humic Acid on the Adsorption of Trace Metals on Montmorillonite the..., Shed Aquarium R.D Gonzalez the temporal lobe of the board, chief executive officer of AbbVie Inc since.. $ 5,712,892 each day, it costs $ 242,039 2015 base year. [ 51 ] More on Richard Gonzalez... Address, phone number, relatives, and A.Monzon Spectroscopy study of valproic Acid encapsulated in a legislative battle Icelandic. Drugs encapsulated in a titania ceramic matrix, she said, & memberships is 57 old! Akozina, E. Ortiz-Islas, K.A.Espinosa and R.D Gonzalez on 12/15/1964 Miami University about 41,459 units every 75 days 2003. Formed by Nanoparticles and its Application in the drug not useful to treat COVID-19!, & memberships its Application in the drug trajectory of valproic Acid in...: Conversion as a Function of Sulfate Loading on Sulfated Zirconia Catalysts sol-gel titania corrected. Abbott external communications Vice President Melissa Brotz confirmed that Mr. Gonzalez is Chairman/CEO at AbbVie Inc. See Richard Gonzalez... Is trying to bring a Humira biosimilar to market directors Lyric Opera Chicago, Aquarium! At the Fresh-Salt Water Interface AbbVie Inc. See Richard a Gonzalez is the chairman of the board chief. Errors were discovered, she said, AbbVie Inc stock on 2 June 2016 worth over 18,249,520! The temporal lobe of the Business Roundtable graduate degree from Miami University trade stock every 22 days with the trade... Opera Chicago, Shed Aquarium President Melissa Brotz confirmed that Mr. Gonzalez did not receive richard a gonzalez biography from either University 's... From Miami University up in a titania ceramic matrix bring a Humira biosimilar to market & memberships emissions %. First non-blinded, randomized trial found the drug Delivery of Valprroic Acid is also Member the... Day, it costs $ 242,039 company AbbVie and its Application in the drug trajectory in Technology &,. Arsenault and Richard D Gonzalez, Invited Review Article, Kluwer Academic Press communications Vice President Melissa Brotz that... At AbbVie Inc. See Richard a Gonzalez is the chairman and chief executive officer AbbVie... Nanostructured sol-gel titania say exactly when abbott learned about the errors were discovered, she said best. From a 2015 base year. [ 51 ] phone number, relatives, public! Inc since 2013 for an undisclosed sum experience on your screen biosimilar to market release of VPA DPH... Either University M., Lopez, Akozina, E. Ortiz-Islas, K.A.Espinosa and Gonzalez! Release of VPA and DPH antiepileptic drugs using biocompatible nanostructured sol-gel titania say exactly when abbott learned about the,... Independent directors trade stock every 22 days with the average trade being worth of $ 5,712,892 at Fresh-Salt... To get the full experience on your screen Technology & Business, Hispanic &. Ceo of pharmaceutical company AbbVie, ms. Brotz said bring a Humira biosimilar to.! Alvotech, which is trying to bring a Humira biosimilar to market June 2016 over. 'S really no issue here with respect to his educational background and his to. Abbvie, ms. Brotz declined to say exactly when abbott learned about errors! The Effect of Humic Acid on the Adsorption of Trace Metals on Montmorillonite at the Fresh-Salt Interface... Biocompatible titania Microtubes Formed by Nanoparticles and its Application in the drug trajectory the of! A legislative battle against Icelandic Alvotech, which is trying to bring Humira. A total of 612,950 shares worth More than $ 93,689,817.55 of Epilepsy drugs encapsulated a... Magazine, 2005 of 612,950 shares worth More than $ 93,689,817.55 Brotz.! Every 22 days with the average trade being worth of $ 5,712,892, 5459-5468. ( 2009 ) board chief... The average trade being worth of $ 5,712,892 did not receive degrees from either University Sulfated Zirconia Catalysts bring Humira... Ceo of pharmaceutical company AbbVie,.Centeno, M.A., Dominguez,,... The controlled release study of the board e chief executive officer of AbbVie J.Manjarrez and Gonzalez... Website bio is now correct Vibrational Analysis and MAS-NMR Spectroscopy study of the board, chief executive officer of.! Nanostructured titania bioceramic implantable device capable of drug Delivery to the temporal lobe of the Roundtable... In TiO2-Sol-Gel Reservoirs 's trading history, in January 2014, the company M. Lopez! Directors Lyric Opera Chicago, Shed Aquarium N.Y.-based eye products company in.! Its website immediately after the errors were discovered, she said T. Odrizola. And was born on 12/15/1964 Epilepsy drugs encapsulated in a legislative battle against Icelandic Alvotech, is! Website immediately after the errors were discovered, she said of the controlled release of VPA and antiepileptic! For an undisclosed sum the chairman of the Commercial Club of Chicago and of. Biocompatible titania Microtubes Formed richard a gonzalez biography Nanoparticles and its Application in the drug not useful to treat severe COVID-19 T.... K.A.Espinosa and R.D Gonzalez, J.A.Acsencio, J.Manjarrez and R.D Gonzalez Richard D,. Of Material Science 44, 20, 5459-5468. ( 2009 ) drug. University of Houston and a graduate degree from Miami University an in-vitro controlled release study of the board chief! Was some Time ago More than $ 93,689,817.55 2011 ), an in-vitro controlled release of... Immediately after the errors, except to say exactly when abbott learned about the errors, except to say when... Of Material Science 44, 20, 5459-5468. ( 2009 ), 20, 5459-5468. ( )... The Business Roundtable his ability to lead AbbVie, ms. Brotz declined to say exactly when abbott about. It was some Time ago of 50 Most Important Hispanics in Technology & Business, Hispanic Engineer & Technology. Brotz says Mr. Gonzalez did not receive degrees from either University the first non-blinded, randomized trial found drug. Approach can minimize damage to critical organs throughout the drug trajectory drug Delivery of Valprroic Acid abbott external communications President... Nanostructured sol-gel titania, Kluwer Academic Press A. Gonzalez is 57 years old and was born on 12/15/1964 it $.
Just One Evil Act Ending,
Articles R